BVMF/PHGN34 (BVMF/PHGN34)

Brazil Stock Exchange: BVMF/PHGN34 · BRL

R$135

-0.90 (-0.7%)· Recorded snapshot

Market cap	141.9B
Revenue (ttm)	104.6B
Net income (ttm)	6.6B
EPS (ttm)	R$6.81
P/E (trailing)	19.8x
P/E (forward)	15.0x
Dividend	R$4.88 (3.62%)
Volume	1
Beta	0.92

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 104.6B
Net income (ttm): 6.6B
EPS (ttm): R$6.81
P/E (trailing): 19.8x
P/E (forward): 15.0x
Market cap: 141.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E15

P25 n/aP50 n/aP75 n/a

Trailing P/E19.8

P25 n/aP50 n/aP75 n/a

ROE10.2

P25 n/aP50 n/aP75 n/a

ROIC7.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/PHGN34 indicators

Market & fundamental data

Available fields

237

Groups with data

Currency

EUR

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	Netherlands
Country code	BR
Earnings date	2026-11-03
Employees	63,670
Employees change	-1,861
Employees growth	-2.79%
Enterprise value	BRL 176.1B
Exchange	Brazil Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1891
Industry	Medical Devices
Is primary listing	No
ISIN number	BRPHGNBDR002
Last earnings date	2026-07-28
Last refreshed	2026-10-29
Market cap	BRL 141.9B
Next earnings date	2026-11-03
Price	BRL 134.82
Price currency	BRL
Sector	Healthcare
SIC code	3845
Stock price date	2026-10-23
Symbol	bvmf/PHGN34
Website	https://www.philips.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	31.45x
Earnings yield	5.05%
EV/Earnings	26.7x
EV/EBIT	17.08x
EV/EBITDA	11.31x
EV/FCF	14.92x
EV/Sales	1.66x
FCF / EV yield	6.7%
FCF yield	8.32%
Forward P/E	15.01x
Graham number	95.38468
Graham upside	-29.25%
Lynch fair value	BRL 31.33
Lynch upside	-76.76%
P/(FCF - SBC) ratio	12.95x
P/(OCF - SBC) ratio	11.21x
P/B ratio	2.09x
P/E ratio	19.8x
P/FCF ratio	12.02x
P/OCF ratio	10.5x
P/S ratio	1.36x
Price/EBITDA ratio	9.92x
Sector forward P/E	11.05x
Sector P/E	41.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	9.78%
EBITDA margin	13.68%
Effective tax rate	24.63%
FCF margin	11.21%
Gross margin	45.94%
Operating margin	9.78%
Pretax margin	8.34%
Profit margin	6.31%
Profit per employee	BRL 103,560
Profitable quarters	6
Profitable years	1
Revenue per employee	BRL 1.6M
ROA	4.07%
ROA (5Y)	1.36%
ROCE	8.96%
ROE	10.15%
ROE (5Y)	-1.95%
ROIC	7.65%
ROIC (5Y)	-5.23%
SBC / revenue	0.81%
Tax / revenue	2.05%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	555%
EPS growth (Q)	61.35%
EPS growth (QoQ)	152.07%
EPS growth 10Y	4.58%
EPS growth 5Y	-0.44%
EPS growth quarters	3
EPS growth years	1
FCF growth	142.58%
FCF growth (Q)	-3.7%
FCF growth (QoQ)	171.3%
FCF growth 3Y	78.43%
FCF growth 5Y	-2.89%
Gross profit growth	3.67%
Gross profit growth (Q)	6.91%
Gross profit growth 3Y	1.91%
Gross profit growth 5Y	0.5%
Net income growth	587.65%
Net income growth (Q)	60%
Net income growth (QoQ)	154.3%
Net income growth 5Y	-0.3%
Net income growth quarters	4
Net income growth years	1
OCF growth	107.64%
OCF growth (Q)	-2.84%
OCF growth (QoQ)	100%
OCF growth 10Y	-2.53%
OCF growth 3Y	43.89%
OCF growth 5Y	-3.46%
Operating income growth	63.48%
Operating income growth (Q)	52.12%
Operating income growth 3Y	79.86%
Operating income growth 5Y	2.05%
Revenue growth	-1.06%
Revenue growth (Q)	0.51%
Revenue growth (QoQ)	11.65%
Revenue growth 10Y	-1.66%
Revenue growth 3Y	-1.29%
Revenue growth 5Y	-0.04%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -1.7B
Depreciation and amortization	BRL 4.1B
EBIT	BRL 10.2B
EBITDA	BRL 14.3B
EPS	BRL 6.81
Financing cash flow	BRL -9.3B
Free cash flow	BRL 11.8B
Free cash flow minus SBC	BRL 11B
Gross profit	BRL 48B
Income taxes	BRL 2.1B
Investing cash flow	BRL -4.6B
Net borrowing	BRL -7B
Net cash flow	BRL -195.3M
Net income	BRL 6.6B
Operating cash flow minus SBC	BRL 12.7B
Operating income	BRL 10.2B
Revenue	BRL 104.6B
Stock-based compensation	BRL 846.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.02
Book value per share	BRL 69.32
Debt / EBITDA	2.86
Debt / equity	0.65
Debt / FCF	3.74
Goodwill	BRL 57.7B
Interest coverage	6.08
Long-term assets	BRL 102.4B
Long-term liabilities	BRL 45.9B
Net cash (debt)	BRL -33.6B
Net cash / market cap	-23.68%
Net debt / EBITDA	2.35
Net debt / equity	0.49
Net debt / FCF	2.85
Piotroski F-Score	7
Property, plant and equipment	BRL 12.9B
Shareholders' equity	BRL 67.9B
Tangible book value	BRL -4.7B
Tangible book value per share	BRL -4.82
Total assets	BRL 158B
Total cash	BRL 10.6B
Total debt	BRL 44.2B
Total liabilities	BRL 90.1B
WACC	7.79%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.67
Current assets	BRL 55.6B
Current liabilities	BRL 44.2B
Current ratio	1.26
Inventory turnover	2.96
Net working capital	BRL 7.5B
Quick ratio	0.73
Working capital	BRL 11.3B
Working capital turnover	55.47

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-3.68%
Dividend growth	-44.76%
Dividend growth (3Y)	0.17%
Dividend growth years	3
Dividend payment date	2026-06-22
Dividend payment years	5
Dividend payout frequency	Annual
Dividend per share	BRL 4.88
Dividend yield	3.62%
Ex-dividend date	2026-05-12
Last dividend	BRL 0.83
Payout ratio	31.78%
Shareholder yield	-0.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 141.14
1D price change	-0.66%
1M price change	5.07%
1M total return	5.07%
1W price change	12.98%
1W total return	12.98%
1Y price change	-12.74%
1Y return CAGR	-9.85%
1Y total return	-9.85%
20-day SMA	BRL 132.26
200-day SMA	BRL 146.13
3M price change	-4.69%
3M total return	-4.69%
3Y price change	46.38%
3Y return CAGR	18.96%
3Y total return	68.36%
50-day SMA	BRL 135.74
50-day SMA vs 200-day SMA	50under200
52-week high	BRL 172.70
52-week high date	2026-02-10
52-week low	BRL 119.33
52-week low date	2026-10-09
6M price change	-7.05%
6M total return	-3.97%
All-time high	BRL 183.41
All-time high date	2024-10-21
All-time low	BRL 60.43
All-time low date	2022-11-03
Average true range (ATR)	BRL 2.98
Average volume	316.5
Beta (5Y)	0.92
Change from 52-week high	-21.93%
Change from 52-week low	12.98%
Change from all-time high	-26.49%
Change from all-time low	123.1%
Change from open	0%
Day's gap	-0.66%
Dollar volume	BRL 135
High price	BRL 134.82
Low price	BRL 134.82
Monthly RSI	49.28
Open price	BRL 134.82
Previous close	BRL 135.72
Price vs 150-day SMA	-4.48%
Price vs 20-day SMA	1.94%
Price vs 200-day SMA	-7.74%
Price vs 50-day SMA	-0.68%
Relative volume	0
RSI	52.38
Sharpe ratio	0.96
Sortino ratio	1.74
Volume	1
Weekly RSI	46.58
YTD price change	-11.1%
YTD total return	-8.15%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	976.8M
Shares change (QoQ)	0%
Shares change (YoY)	3.68%
Shares held by insiders	0.06%
Shares held by institutions	59.85%

Deeper analysis on BVMF/PHGN34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/PHGN34 report

Is a complete BVMF/PHGN34 research report available?

No complete published report is available for bvmf/PHGN34 (BVMF/PHGN34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/PHGN34 (BVMF/PHGN34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/PHGN34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/PHGN34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/PHGN34

Frequently asked questions